Prof Megan Munsie
Prof Megan Munsie
Megan Munsie PhD is a highly experienced interdisciplinary researcher who combines her scientific expertise with a deep understanding of the ethical, legal and societal implications of stem cell science and its clinical translation.
Her work focuses on understanding community attitudes and expectation in regenerative medicine and other emerging technologies, and the development of policy and professional standards to enable responsible translation of stem cell and related research. Findings from her research have influenced policy reforms at a national and international level, and informed the design and delivery of educational resources for patients, healthcare professionals and the general public for over a decade.
She has been involved in stem cell research since the mid 1990s, has led public education and policy activities for a series of major Australian Government funded programs in stem cell science, and currently heads the preparedness program for the international Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW). She is also a Professor of Emerging Technology (Stem Cells) at the Melbourne Medical School and co-lead of the University of Melbourne Collaborative for Better Health and Regulation.
Megan is a board member of the International Society for Stem Cell Research and the National Stem Cell Foundation of Australia. She is the immediate past President of the Australasian Society for Stem Cell Research (ASSCR) having held leadership roles on the ASSCR Committee for more than ten years. She also serves on advisory committees to peak national and international bodies including the International Society for Stem Cell Research and International Society for Cell and Gene Therapy.
She has extensive experience in biotechnology and has also worked for ten years as a clinical embryologist in Australian IVF clinics. She completed her Masters and PhD at Monash University and her science degree at the Queensland University of Technology.
Her work focuses on understanding community attitudes and expectation in regenerative medicine and other emerging technologies, and the development of policy and professional standards to enable responsible translation of stem cell and related research. Findings from her research have influenced policy reforms at a national and international level, and informed the design and delivery of educational resources for patients, healthcare professionals and the general public for over a decade.
She has been involved in stem cell research since the mid 1990s, has led public education and policy activities for a series of major Australian Government funded programs in stem cell science, and currently heads the preparedness program for the international Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW). She is also a Professor of Emerging Technology (Stem Cells) at the Melbourne Medical School and co-lead of the University of Melbourne Collaborative for Better Health and Regulation.
Megan is a board member of the International Society for Stem Cell Research and the National Stem Cell Foundation of Australia. She is the immediate past President of the Australasian Society for Stem Cell Research (ASSCR) having held leadership roles on the ASSCR Committee for more than ten years. She also serves on advisory committees to peak national and international bodies including the International Society for Stem Cell Research and International Society for Cell and Gene Therapy.
She has extensive experience in biotechnology and has also worked for ten years as a clinical embryologist in Australian IVF clinics. She completed her Masters and PhD at Monash University and her science degree at the Queensland University of Technology.
Megan Munsie PhD is a highly experienced interdisciplinary researcher who combines her scientific expertise with a deep understanding of the ethical, legal and societal implications of stem cell science and its clinical translation.
Her work...
Her work...
Megan Munsie PhD is a highly experienced interdisciplinary researcher who combines her scientific expertise with a deep understanding of the ethical, legal and societal implications of stem cell science and its clinical translation.
Her work focuses on understanding community attitudes and expectation in regenerative medicine and other emerging technologies, and the development of policy and professional standards to enable responsible translation of stem cell and related research. Findings from her research have influenced policy reforms at a national and international level, and informed the design and delivery of educational resources for patients, healthcare professionals and the general public for over a decade.
She has been involved in stem cell research since the mid 1990s, has led public education and policy activities for a series of major Australian Government funded programs in stem cell science, and currently heads the preparedness program for the international Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW). She is also a Professor of Emerging Technology (Stem Cells) at the Melbourne Medical School and co-lead of the University of Melbourne Collaborative for Better Health and Regulation.
Megan is a board member of the International Society for Stem Cell Research and the National Stem Cell Foundation of Australia. She is the immediate past President of the Australasian Society for Stem Cell Research (ASSCR) having held leadership roles on the ASSCR Committee for more than ten years. She also serves on advisory committees to peak national and international bodies including the International Society for Stem Cell Research and International Society for Cell and Gene Therapy.
She has extensive experience in biotechnology and has also worked for ten years as a clinical embryologist in Australian IVF clinics. She completed her Masters and PhD at Monash University and her science degree at the Queensland University of Technology.
Her work focuses on understanding community attitudes and expectation in regenerative medicine and other emerging technologies, and the development of policy and professional standards to enable responsible translation of stem cell and related research. Findings from her research have influenced policy reforms at a national and international level, and informed the design and delivery of educational resources for patients, healthcare professionals and the general public for over a decade.
She has been involved in stem cell research since the mid 1990s, has led public education and policy activities for a series of major Australian Government funded programs in stem cell science, and currently heads the preparedness program for the international Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW). She is also a Professor of Emerging Technology (Stem Cells) at the Melbourne Medical School and co-lead of the University of Melbourne Collaborative for Better Health and Regulation.
Megan is a board member of the International Society for Stem Cell Research and the National Stem Cell Foundation of Australia. She is the immediate past President of the Australasian Society for Stem Cell Research (ASSCR) having held leadership roles on the ASSCR Committee for more than ten years. She also serves on advisory committees to peak national and international bodies including the International Society for Stem Cell Research and International Society for Cell and Gene Therapy.
She has extensive experience in biotechnology and has also worked for ten years as a clinical embryologist in Australian IVF clinics. She completed her Masters and PhD at Monash University and her science degree at the Queensland University of Technology.
Top Publications
- Munsie, M, Findlay, JK. Three-Dimensional Models of Implantation Using Human Stem Cells: Scientific Insights and Broader Considerations.. Biomolecules 15(7) : 2025 view publication
- Jonlin, EC, Fujita, M, Isasi, R, Kato, K, Munsie, M, Muto, K, Niakan, K, Saha, K, Sugarman, J, Turner, L, et al. What does "appropriate scientific justification" mean for the review of human pluripotent stem cell, embryo, and related research?. Stem Cell Reports 20(5) : 102479 2025 view publication
- Pang, PC-I, Munsie, M, Chang, S. A Method for Analyzing Navigation Flows of Health Website Users Seeking Complex Health Information with Google Analytics. Informatics 10(4) : 80 -80 2025 view publication
- Rees, L, Friis, T, Woodward-Kron, R, Munsie, M. What is known about healthcare professional-patient communication when discussing stem cell therapies? A scoping review.. Patient Educ Couns 130: 108430 2025 view publication
- Ikonomou, L, Munsie, M, Power, C, Sipp, D, Turner, L, Rasko, JEJ. Effective regulatory responses to predatory stem cell markets in Australia and Canada.. Cell Stem Cell 31(10) : 1393 -1397 2024 view publication
Page 1 of 16
Career information
Share //
